Christine Gaspin
- Molecular Biology top 5%
- RNA and protein synthesis mechanisms 24
- Genomics and Phylogenetic Studies 21
- RNA modifications and cancer 16
- Genetics top 5%
- Bacterial Genetics and Biotechnology 6
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 5
- Ecology top 5%
- Endocrinology top 10%
-
- Cancer-related molecular mechanisms research 6
-
- Plant Disease Resistance and Genetics 5
-
- AI-based Problem Solving and Planning 4
- Co-authors
- Pascale RombyThomas SchiexClément ChevalierFrançois VandeneschThomas GeissmannPierre FechterSandrine BoissetÉric Westhof
- Partner nations
- FranceUnited StatesMorocco
In The Last Decade
Christine Gaspin
49 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 1.3k
- Genetics 507
- Infectious Diseases 329
- Ecology 328
- Endocrinology 49
Countries citing papers authored by Christine Gaspin
This map shows the geographic impact of Christine Gaspin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Gaspin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Gaspin more than expected).
Fields of papers citing papers by Christine Gaspin
This network shows the impact of papers produced by Christine Gaspin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Gaspin. The network helps show where Christine Gaspin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christine Gaspin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 11 | |
| 9 | 2019 | 26 | |
| 10 | 2016 | 63 | |
| 11 | 2015 | 7 | |
| 12 | 2015 | 15 | |
| 13 | 2011 | 30 | |
| 14 | 2011 | 21 | |
| 15 | 2010 | 107 | |
| 16 | 2009 | 176 | |
| 17 | 2007 | 364 | |
| 18 | 2001 | 58 | |
| 19 | 2000 | 141 | |
| 20 | 1994 | 62 |
About Christine Gaspin
Christine Gaspin is a scholar working on Molecular Biology, Cancer Research and Parasitology, having authored 54 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (24 papers), Genomics and Phylogenetic Studies (21 papers), RNA modifications and cancer (16 papers), Bacterial Genetics and Biotechnology (6 papers), Cancer-related molecular mechanisms research (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Plant Disease Resistance and Genetics (5 papers) and AI-based Problem Solving and Planning (4 papers). The work is most often cited by research in Molecular Biology (1.3k citations), Genetics (507 citations) and Infectious Diseases (329 citations). Christine Gaspin has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include Pascale Romby, Thomas Schiex, Clément Chevalier, François Vandenesch, Thomas Geissmann, Pierre Fechter, Sandrine Boisset, Éric Westhof, Gaël Erauso and Jean‐Pierre Bachellerie. Their work appears in journals such as Nucleic Acids Research, Genes & Development and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.